Related Experiment Video

Updated: Jun 17, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

[Therapeutic monoclonal antibodies in the French community: let's get organized]

Delphine Watiez1, Hervé Watier

  • 1D. Watiez : journaliste scientifique, 16-32 résidence Breteuil, parc Saint-Maur, 59800 Lille, France. dwatiez@numericable.fr

Medecine Sciences : M/S
|December 29, 2009
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Experiment Videos

Last Updated: Jun 17, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

Articles linked to this work by shared authors, journal, and citation graph.

From the Gorgon's blood to Behring's Blutserumtherapie: A long path towards serum therapy.

Immunological reviews·2024

Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells.

Frontiers in immunology·2024

Albumin influences leucocyte FcRn expression in the early days of kidney transplantation.

Clinical and experimental immunology·2024

Why is there no biosimilar of Erbitux®?

Journal of pharmaceutical and biomedical analysis·2023

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.

mAbs·2023

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods.

International journal of molecular sciences·2023

[Sex-specific depression risk].

Medecine sciences : M/S·2026

[Ambiguities of medicine in the face of forms of death].

Medecine sciences : M/S·2026

[Mobilization of Long Covid patients: from lived experience to the co-construction of research and care pathways].

Medecine sciences : M/S·2026

[The environment's contribution to the spread of antibiotic resistance].

Medecine sciences : M/S·2026

[Syphilis and human treponemes: a long evolutionary history revealed by paleogenomics].

Medecine sciences : M/S·2026

[Drug repurposing to combat viral infectious diseases: principles and illustration with Prozac®].

Medecine sciences : M/S·2026

How I Treat: Transplantation for primary immune regulatory diseases and inflammatory disorders.

Journal of human immunity·2026

Immunoglobulins as replacement therapy in hematological malignancies: from historical hypogammaglobulinemia to the era of T-cell-engaging therapies.

Expert review of hematology·2026

Advances in Human and Animal Germinal Center Models In Vitro: New Approaches to Studying Immune Responses.

BioMed research international·2026

In vitro generation of regulatory T cells: A challenging tool for studying immune aging in humans.

FEBS open bio·2026

[The impact of the World War I (1914-1918) on evolution of transfusion medicine].

Khirurgiia·2026

Simultaneous immune checkpoint blockade-associated diabetes mellitus and thyrotoxicosis.

JCEM case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us